The Experts in Animal Health

printer friendly version

Brakke Consulting’s
Animal Health News & Notes for August 19, 2011
Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon, DVM MBA
Brakke news
market research
earnings news
other news
Boehringer Ingelheim Vetmedica
Pegasus Labs

Throughout the year, Brakke Consulting, Inc., performs market research surveys and studies for client companies.  If your firm needs help assessing the feasibility of a new product or technology, identifying the opinions and trends of product consumers, or determining the current market for products, Brakke Consulting, Inc. can build a market study to meet your needs. 
We have a database in place of several thousand small animal veterinarians and the ability to custom-tailor surveys of other animal health consumers.  We also produce syndicated studies in specific animal health market areas.   Further information can be found at our website or by calling our Dallas office at 972.243.4033.
> PetSmart reported results for the second quarter of 2010. Total sales for the second quarter of 2011 increased 7% to $1.5 billion. Net income totaled $61 million in the second quarter of 2011, an increase of 27% compared to the second quarter of 2010.  (Business Wire)
> ImmuCell Corporation announced the results of its operations for the three-months ended June 30, 2011. Product sales increased by 16% to $1.25 million in comparison to the same period in 2010; during this current period, animal health sales increased by 32%. Due principally to Mast Out product development expenses, the net loss was ($258,000) in comparison to a net loss of ($6,000) during the same period in 2010. (company press release)
> JBS SA reported results for its quarter ended June 30, 2011.  The company reported a net loss of (BR 181 million) ($114 million) on sales that totaled BR 14.6 billion ($9.2 billion).  JBS cited decreased income in its US beef/cattle operations and huge losses in its US chicken operations. (Feedstuffs) 
> Boehringer Ingelheim Vetmedica announced it is expanding its state-of-the-art biological GMP manufacturing facility in St. Joseph, Missouri. The expansion will increase the size of the plant by more than 50%. Upon completion of the expansion to the facility, BIV will be producing several more cattle vaccine product lines at the facility. (Vet Advantage) 
> Novartis Animal Health announced an investment to significantly expand its Novartis Centre for Aqua Research & Development on Prince Edward Island (PEI) in Canada. Construction has already begun on the US$2.8 million expansion. (Feedstuffs) 
> Pegasus Laboratories announced that PRN Pharmacal’s Proin (phenylpropanolamine hydrochloride) Chewable Tablets has received a New Animal Drug Approval (NADA #141-324) from the FDA Center of Veterinary Medicine. Proin is approved for the control of canine urinary incontinence due to urethral sphincter hypotonus. (company press release)
> IDEXX announced the launch of the IDEXX SNAP BVD Test. This simple on-farm or in-clinic test detects bovine viral diarrhea virus (BVDV) antigen in just 20 minutes using large ear-notch samples and is the first IDEXX rapid assay for livestock disease. (Vet Advantage)
> scil animal care announced the addition of the Spotchem EL, a small electrolyte analyzer that delivers fast results in three easy steps. (company press release)
> Cargill announced it has made a binding offer to acquire Provimi for an enterprise value of EUR 1.5 billion ($2.16 billion) from private equity firm Permira funds. (Meating Place)
> Trouw Nutrition International announced the launch of MaxCare CelSius, a new mineral supplement to relieve the effects of heat stress in dairy cows. (Feedstuffs)
> UK  Dechra Veterinary Products introduced carprofen formulations for cats and dogs as part of its Veterinary Essentials range of generic medicines in the UK.  Rycarfa is available in tablet form for dogs and as an injectable solution for both cats and dogs. (Animal Pharm)
> FRANCE – RABIES   Officials in Paris confirmed a case of canine rabies case in a puppy that originated in Morocco.  The 2.5-month-old puppy was adopted from Morocco and brought to France without compliance with rabies health requirements. The last French rabies case was diagnosed May 10, 2009. (Vet Practice News)
> US – WEST NILE VIRUS   Two Texas horses have tested positive for West Nile virus (WNV) in two different counties. Last week, WNV was confirmed in horses in California and Nevada, and a Georgia horse tested positive for the disease in late July. (

The Kansas City Animal Health Corridor cordially invites the animal health industry to join us for an exclusive gathering of animal health CEOs and industry leaders from across the country and around the world.  Highlights include celebrity guest Ty Murray, the “King of Cowboys,” and Iron Paw honoree Joerg Ohle.
For details or to register for the event, go to
Congratulations to the Banfield management team in the completion of another successful Pet Healthcare Industry Summit.  The program was both informative and thought stimulating regarding the US economy, US political scene and various issues facing the veterinary profession. We also want to congratulate John Payne on his retirement from active management at Banfield the end of 2011.  Another well-done accomplishment John!
This week you’ll note there were a number of new products and investments in the animal health space announced.  A number of these are significant and provide some nice opportunities for growing the market.  We’re always appreciative of investments in animal health to keep the flow of innovation moving forward in these challenging economic times. 
Which brings me to the topic of the Kansas City Animal Health Investment Forum.  If you’ve not already registered for this event; please do so in the next few days – the deadline for registration is August 23.  You can register at .  There are some interesting new companies presenting their technology on August 30th in KC. See you all there!!
Have a great weekend and stay cool!!

Ron Brakke

This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at
Brakke Consulting, Inc.
2735 Villa Creek, Suite 140
Dallas, TX  75234    USA

en_USEnglish (United States)